Perry stepped down effective Dec. 30 to join an unnamed biotechnology company as its CFO, according to a press release.
McAllister was vice president of finance & administration for Biomet from 2007 until this year. His résumé also includes stints at Johnson & Johnson‘s (NYSE:JNJ) DePuy subsidiary and Howmedica, now a division of Stryker (NYSE:SYK).
“Steve McAllister brings expertise in both finance and in the operations of device companies. I am confident that he will provide the same judgment, integrity and strategic vision provided by Greg Perry during our initial repositioning of InVivo,” interim CEO Michael Astrue said in prepared remarks.
Perry took over financial operations for the Cambridge, Mass.-based medtech company in September from Sean Moran, who quit after just 2 weeks in the role. Moran had taken the job after the sudden departure of CEO & CFO Frank Reynolds, who resigned late in August.
InVivo said it also promoted William D’Agostino to vice president of manufacturing & engineering and Robert Ham to senior director of quality. Both appointments are slated take effect Jan. 1.
Varian Imaging president retires
Robert H. Kluge, president of Varian Medical (NYSE:VAR) subsidiary Varian Imaging, has retired. Kluge is scheduled be replaced by T-System CEO Sunny Sanyal on Feb. 3.
Boston Scientific names private equity firm co-founder to board
Boston Scientific (NYSE:BSX) named David Roux, the co-founder of private equity firm Silver Lake, to its board of directors. Roux was an executive at Oracle Corp. (NSDQ:ORCL) and Liberate Technologies.
Stryker director steps down
Stryker (NYSE:SYK) said board member Howard Lance will step down because of his increasing responsibilities with his private equity firm, The Blackstone Group. His departure is expected to be effective March 31.
Orthofix adds to its board
Orthofix (NSDQ:OFIX) said it added Dr. Anthony Martin to its board of directors. Martin also sits on the board for Sphere Medical (LON:SPHR) and Phico Therapeutics Ltd.